PON1 and type 2 diabetes mellitus: firstly aimed to estimate serum PON activity in patients with non-insulin dependent diabetes (NIDDM) and its relationship to diabetic complications, including nephropathy, retinopathy, neuropathy and macroangiopathy [18].